| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/10/1999 | CN1207740A Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| 02/10/1999 | CN1207675A Sublingual and buccal administration of selegiline |
| 02/10/1999 | CN1207316A Pile eliminating powder |
| 02/10/1999 | CN1207312A Capsule for treating apoplexy sequela and its producing method |
| 02/10/1999 | CN1207294A Potassium and magnesium controlled-release tablet and producing method thereof |
| 02/09/1999 | US5869663 Intermediates for neurokinin receptor antagonists |
| 02/09/1999 | US5869637 Human Kallikrein |
| 02/09/1999 | US5869539 Source of nitric oxide; administering to treat hypertension, or where increased blood flow is desirable; no negative side effects due to drug metabolites |
| 02/09/1999 | US5869534 Administering aminoguanidine and analogs thereof to reduce lipid oxidation and inhibit an increase in serum low density lipoproteins to prevent disease states characterized by the presence of advanced glycosylation endproducts |
| 02/09/1999 | US5869531 No undesireable salidiuretic properties; treating ischemia induced disorders |
| 02/09/1999 | US5869523 Protecting forskolin, deacetylating, treating with beta-halopropionyl halide, treating with alkali, acetylating, reacting with amine, deprotecting |
| 02/09/1999 | US5869516 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 02/09/1999 | US5869509 Treat disorders responsive to openers of the large conductance calcium-activated potassium channels |
| 02/09/1999 | US5869495 Treatment and/or prophylaxis of hyperglycaemia |
| 02/09/1999 | US5869486 Fused pyrimidines and pyriazines as pharmaceutical compounds |
| 02/09/1999 | US5869478 Administering as antiischemic agents |
| 02/09/1999 | US5869455 Serine protease inhibitors-N-substituted derivatives |
| 02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/09/1999 | US5869265 Screening modulators by contacting recombinant cells which express cotransporter with substance, determining increase or decrease in activity; anticholesterol agents; antidiabetic agents; liver disease; crohn's disease |
| 02/09/1999 | US5869044 Method for the treatment or prophylaxis of ischemia-reperfusion injury |
| 02/09/1999 | US5869037 Adenoviral-mediated gene transfer to adipocytes |
| 02/09/1999 | CA2226091C Cyclosporin-containing soft capsule preparations |
| 02/06/1999 | CA2239256A1 Novel lgt |
| 02/05/1999 | CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/04/1999 | WO1999005175A2 Diagnosis and treatment of diseases using anti-anti-t-cell receptor vbeta anti-bodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein i (esrp1) |
| 02/04/1999 | WO1999005164A1 Process for preparing pharmacologically acceptable salts of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl amino acids |
| 02/04/1999 | WO1999005147A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 02/04/1999 | WO1999005144A1 Novel compounds |
| 02/04/1999 | WO1999005143A1 Novel compounds |
| 02/04/1999 | WO1999005142A1 Novel compounds |
| 02/04/1999 | WO1999005134A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 02/04/1999 | WO1999005132A1 Benzothia(oxa)diazol derivatives and their use as endothelin-receptor antagonists |
| 02/04/1999 | WO1999005131A1 1,3-diaza- heterocycles and their use as nitric oxide synthase inhibitors |
| 02/04/1999 | WO1999005113A1 Substituted 6-phenylphenanthridines |
| 02/04/1999 | WO1999005112A1 Substituted 6-alkylphenanthridines |
| 02/04/1999 | WO1999005111A1 Novel tetrazole derivatives |
| 02/04/1999 | WO1999005107A1 Vitronectin receptor antagonist |
| 02/04/1999 | WO1999005105A1 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
| 02/04/1999 | WO1999004796A1 Fibrinogen receptor antagonists |
| 02/04/1999 | WO1999004795A1 Delta opioid receptor agonist for reducing ischemic damage |
| 02/04/1999 | WO1999004794A1 Cyclic amine modulators of chemokine receptor activity |
| 02/04/1999 | WO1999004791A1 A pharmaceutical composition active in reducing production of mcp-1 protein |
| 02/04/1999 | WO1999004770A2 A pharmaceutical composition active in reducing production of mcp-1 protein |
| 02/04/1999 | WO1999004636A1 Evaluation of, delivery of, and use of agents to treat heart disorders |
| 02/04/1999 | WO1998050079A3 Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes |
| 02/04/1999 | CA2298507A1 A pharmaceutical composition active in reducing production of mcp-1 protein |
| 02/04/1999 | CA2297923A1 Novel tetrazole-substituted 6-phenyl-pheanathridines as pde inhibitors |
| 02/04/1999 | CA2297910A1 Vitronectin receptor antagonist |
| 02/04/1999 | CA2297909A1 Fibrinogen receptor antagonists |
| 02/04/1999 | CA2297328A1 Evaluation of, delivery of, and use of agents to treat heart disorders |
| 02/04/1999 | CA2297315A1 Endothelin receptor antagonists |
| 02/04/1999 | CA2297251A1 Delta opioid receptor agonist for reducing ischemic damage |
| 02/04/1999 | CA2297166A1 1,3-diaza- heterocycles and their use as nitric oxide synthase inhibitors |
| 02/04/1999 | CA2296648A1 Novel compounds |
| 02/04/1999 | CA2296518A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 02/04/1999 | CA2296426A1 Novel compounds |
| 02/04/1999 | CA2296314A1 Cyclic amine modulators of chemokine receptor activity |
| 02/03/1999 | EP0894863A1 A YAK-1 related serine/threonine protein kinase-HTLAR33 |
| 02/03/1999 | EP0894861A2 Glycogen phosphorylase from Streptococcus pneumoniae |
| 02/03/1999 | EP0894856A1 A human sMAD3 splice variant |
| 02/03/1999 | EP0894855A2 Human I kappa B-beta transcription factor |
| 02/03/1999 | EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor |
| 02/03/1999 | EP0894796A1 Imidazolines substituted with a heterocyclic ring as alpha-2 antagonists |
| 02/03/1999 | EP0894093A2 Soluble tachykinin antagonists, the preparation and use thereof |
| 02/03/1999 | EP0894089A1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| 02/03/1999 | EP0894088A1 Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds |
| 02/03/1999 | EP0894085A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
| 02/03/1999 | EP0894084A1 Cinnamic acid derivatives and their use as integrin antagonists |
| 02/03/1999 | EP0894003A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors |
| 02/03/1999 | EP0893996A1 Use of rapamycin derivatives in vasculopathies and xenotransplantation |
| 02/03/1999 | EP0729352B1 Interdigitation-fusion liposomes containing arachidonic acid metabolites |
| 02/03/1999 | CN1207044A Cyclosporin-containing soft capsule preparations |
| 02/03/1999 | CN1206712A Heterocyclic compound, preparation process thereof and medicinal composition containing same |
| 02/03/1999 | CN1206595A Thrombus dissolving Guiluchun |
| 02/03/1999 | CN1206589A Process for preparing medicine composition |
| 02/03/1999 | CN1041938C Triterpene derivatives and endothelin-receptor antagonists containing the same |
| 02/03/1999 | CN1041937C Androstane derivatives and pharmaceutical composition containing them and process for preparing same |
| 02/03/1999 | CN1041930C [1,2,4] triazolo [4,3-1] quinoxaline derivatives, their preparation and use |
| 02/03/1999 | CN1041923C Piperzine derivatives and preparation process and usage thereof |
| 02/02/1999 | US5866717 Metalloproteinase inhibitors |
| 02/02/1999 | US5866702 Purine inhibitors of cyclin dependent kinase 2 |
| 02/02/1999 | US5866681 Oligopeptides |
| 02/02/1999 | US5866611 Phenoxypropylamine inhibitors of squalene synthese, useful in treating diseases in which a lowering of cholesterol is desirable. |
| 02/02/1999 | US5866610 Substituted benzoylguanidines, process for their preparation, their use as a pharmaceutical as inhibitors of the cellular NA+/H+ exchange or as a diagnostic, and pharmaceutical containing them |
| 02/02/1999 | US5866604 Thiol derivatives with metallopeptidase inhibitory activity |
| 02/02/1999 | US5866598 4h-carbazol-4-ones |
| 02/02/1999 | US5866587 Hydroxamide derivatives of fused piperidine derivatives |
| 02/02/1999 | US5866579 Imidazole and imidazoline derivatives and uses thereof |
| 02/02/1999 | US5866571 Treatment of inflammations, thromboembolic diseases and cardiovascular diseases. |
| 02/02/1999 | US5866568 Heterocyclic compounds |
| 02/02/1999 | US5866551 Therapy for atherosclerosis |
| 02/02/1999 | US5866540 Cyclic adhesion inhibitors |
| 02/02/1999 | US5866160 Human therapy |
| 02/02/1999 | US5866123 Gene encoding cationic amino acid transporter protein |
| 02/02/1999 | CA2053275C Fibroblast growth factor conjugates |
| 02/02/1999 | CA1340362C Thiadiazinones |
| 02/02/1999 | CA1340361C N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists |
| 02/01/1999 | CA2238670A1 A novel smad3 splice variant as a target in chronic renal failure, atherosclerosis and fibrosis |
| 01/30/1999 | CA2244435A1 New heterocyclic compounds, their preparation process and the pharmaceutical compounds containing them |
| 01/29/1999 | CA2239266A1 Novel histidine kinase |